Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Gabapentin NDC 71610-126 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 100 mg - 71610 0126 60
This appears to be a prescription label for Gabapentin medication. The medication comes in capsule form with a strength of 100mg and the prescription includes 90 capsules. Unfortunately, no further information is available to provide a more detailed description.*
Aphena Pharma Solutions - TN - Aphena
Formula - gabapentin fig1
This text appears to be a formula for calculating Lt (probably a medical measurement). It suggests multiplying the patient's age in years by their weight in kilograms, and then multiplying the result by a value given for creatinine (0.85 for female patients). However, without further context, it is difficult to determine the purpose or significance of this formula.*
Figure 1 - gabapentin fig2
This is a graph showing the mean pain score over a period of 7 weeks in a study evaluating the effectiveness of Gabapentin compared to a placebo. The dose titration period was not specified, but there was a 4-week fixed dose period. The mean pain score was 10 at baseline and at weeks 1-7.*
Figure 2 - gabapentin fig3
Figure 3 - gabapentin fig4
The text seems to be part of a research study report on patients with Postherpetic neuralgia (PHN). The text presents the percentage of patients that had a reduction in pain score and the results of a controlled study with Placebo and GBP (Gabapentin) at different doses. The symbol #p<001 suggests that the differences between the placebo and GBP groups are statistically significant. Overall, without further context, it is difficult to draw further conclusions.*
Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5
Chemical Structure - gabapentin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.